COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is a lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), and even less is available in patients on maintenance hemodialysis therapy than in the general population. In this retrospective, observational, single-center study, we analyzed the clinical course and outcomes of all maintenance hemodialysis patients hospitalized with COVID-19 from March 12th to April 10th, 2020 as confirmed by real-time polymerase chain reaction.
Source: Kidney International - Category: Urology & Nephrology Authors: Marian Goicoechea, Luis Alberto S ánchez Cámara, Nicolás Macías, Alejandra Muñoz de Morales, Ángela González Rojas, Arturo Bascuñana, David Arroyo, Almudena Vega, Soraya Abad, Eduardo Verde, Ana María García Prieto, Úrsula Verdalles, Diego Barb Tags: Editorial: Special Report Source Type: research
More News: China Health | Coronavirus | COVID-19 | Dialysis | Hemodialysis | Maca | Pneumonia | Respiratory Medicine | SARS | Spain Health | Study | Urology & Nephrology